Complementary utility of targeted next-generation sequencing and immunohistochemistry panels as a screening platform to select targeted therapy for advanced gastric cancer.

导出 OA

翻译打印收藏纠错

第一作者： Hyo Song,Kim

第一单位： Division of Medical Oncology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea.

作者： Hyo Song,Kim ^[1] ; Hanna,Lee ^[2] ; Su-Jin,Shin ^[3] ; Seung-Hoon,Beom ^[1] ; Minkyu,Jung ^[1] ; Sujin,Bae ^[2] ; Eun Young,Lee ^[2] ; Kyu Hyun,Park ^[4] ; Yoon Young,Choi ^[5] ; Taeil,Son ^[5] ; Hyoung-Il,Kim ^[5] ; Jae-Ho,Cheong ^[5] ; Woo Jin,Hyung ^[5] ; Jun Chul,Park ^[6] ; Sung Kwan,Shin ^[6] ; Sang Kil,Lee ^[6] ; Yong Chan,Lee ^[6] ; Woong Sub,Koom ^[7] ; Joon Seok,Lim ^[8] ; Hyun Cheol,Chung ^[9] ; Sung Hoon,Noh ^[5] ; Sun Young,Rha ^[9] ; Hyunki,Kim ^[3] ; Soonmyung,Paik ^[2]

作者单位： Division of Medical Oncology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea. ^[1] Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, Republic of Korea. ^[2] Hanyang University, College of Medicine, Republic of Korea. ^[3] Cancer Metastasis Research Center, Song Dang Institute for Cancer Research, Yonsei University College of Medicine, Seoul, Republic of Korea. ^[4] Department of Surgery, Yonsei University College of Medicine, Seoul, Republic of Korea. ^[5] Division of Gastroenterology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea. ^[6] Department of Radiation Oncology, Yonsei University College of Medicine, Seoul, Republic of Korea. ^[7] Department of Radiology, Yonsei University College of Medicine, Seoul, Republic of Korea. ^[8] Division of Medical Oncology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea.;Cancer Metastasis Research Center, Song Dang Institute for Cancer Research, Yonsei University College of Medicine, Seoul, Republic of Korea. ^[9]

关键词 gastric cancer immunohistochemistry matched therapy molecular subtypes next-generation sequencing